3rd Annual Protein and Peptide Formulation Strategies for Drug Development and Delivery

Venue: Hilton San Francisco

Location: San Francisco, California, United States

Event Date/Time: Mar 29, 2004 End Date/Time: Mar 31, 2004
Report as Spam


The Institute for International Research is proud to present the 3rd Annual Protein and Peptide Formulation Strategies for Drug Development and Delivery Conference. The mission of this conference, specially designed for protein and peptide formulation experts, is to uncover formulation and stability strategies for efficient drug development in order to further expand delivery options. The 3rd annual conference provides formulation and stability fundamentals, coupled with a concentration of the latest safe and effective drug delivery systems advancements.

Maximize the science that drives formulation, process, delivery, and commercialization.

Key Features of Day One: Workshops

Day one begins with an in-depth pre-conference workshop on Applications for Nanoparticle Design and Microfabrication in Protein and Peptide Delivery. This workshop allows participants to assess where nano and micro technology might fit into their organization. The afternoon workshop addresses Strategies for Understanding and Measuring Immunogenicity of Recombinant Protien Therapeutics presented by Meena Subramanyam, PhD, Director, Clinical Science Technology BIOGEN IDEC and Eric Wakshull, PhD Principal Scientist, Clinical Science and Technology BIOGEN IDEC. This workshop details implementing appropriate assays to determine immunogenicity of protein therapeutics.

Key Features of Day Two

Physical and Chemical Stability

Keynote Presentation: Protein Aggregation in Aqueous Solution: Mechanism, Inhibition and Reversal

John Carpenter, PhD
Associate Professor Pharmaceutics

Featured Presentation: A Phase Diagram/High Throughput Screening Approach to Protein and Vaccine Formulation

C. Russell Middaugh, PhD
Takeru and Aya Higuchi Distinguished Professor

MEDIMMUNE VACCINES presents formulation to stabilize live vaccines for room temperature storage
MERCK AND CO presents a case study on formulation challenges for protein and peptide stability in solution
Processing of Proteins and Peptides

Featured Presentation: Stabilization of Proteins by Freeze Drying: Stability Prediction by Materials Science

Michael Pikal, PhD

Technology Pavilion

Attend a series of innovative technology presentations from the leaders in protein and peptide formulation and drug delivery technology.

Key Features of Day Three

Protein and Peptide Delivery

Guy Furness, Editor, DRUG DELIVERY AND COMMERCE, presents drug delivery nanotechnology: finding and understanding the reality behind the hype and skepticism

EMISPHERE TECHNOLOGY, INC addresses oral administration: breakthroughs, challenges, and opportunities
THE JOHNS HOPKINS UNIVERSITY presents targeted delivery using new polymeric carriers
AMGEN identifies delivery strategies for peptides.
PANEL DISCUSSION: Determine appropriate formulation strategies for injectable, intranasal, pulmonary, and oral delivery mechanisms through expert led panel discussion
Regulatory Considerations

Former FDA Researcher-Reviewer and current Director of Regulatory for MEDIMMUNE walks through a complete submission process, highlighting lessons learned.

HELLER EHRMAN WHITE AND MCAULIFFE presents strategies to anticipate regulatory change to follow technological advances.
In its third year, IIR’s Protein and Peptides conference presents an opportunity to gain exposure to companies and industry experts leading the pace toward selecting the most appropriate formulation for a protein or peptide drug for efficient, cost effective, patient compliance, and safety. If you are involved in protein or peptide formulation and delivery at a pharmaceutical or biotech company, drug delivery company, academic research institute or CRO you will benefit by attending this industry gathering.